Replies to post #27267 on Ayala Pharmaceuticals Inc (fka ADXS)

[Traderbx]

Wasn't the Amgen deal a big one? Yet it is not reflected in the share price at all...

[BarrellofHay]

Why would Adage care about shorting ADXS. lets suppose that the 10 million shares short was Adage completely. The most they would have made is about $8 bucks worth or 80 million dollars. That same money in just about any mid cap bio would have made more money. If its about keeping the shares down to buy more, well, they have not been buying more. The fact is, its arrogant to think that adage even thinks about ADXS more than 5 minutes a month.

[BarrellofHay]

I was expecting more comments on my "lack of scientific evidence and trial data" as the reason for low stock price. Was being provocative and hoping somebody would "set me straight" with info that I perhaps have missed. But maybe I am right and there really is not enough evidence to definitely say that ADXS technology even works. If it doesnt then shorts are right and this is a 0 dollar stock in 3 years

[BarrellofHay]

Thanks dew. Thing about neo is it's totally unproven and 6 years from market or about 6 dilutions away. By the time it hits market there will be 500 million shares outstanding